- Home
- KMDA vs IHRT Comparison
KMDA vs IHRT Comparison
Compare KMDA & IHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- IHRT
- Stock Information
- Founded
- KMDA 1990
- IHRT N/A
- Country
- KMDA Israel
- IHRT United States
- Employees
- KMDA N/A
- IHRT N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- IHRT Broadcasting
- Sector
- KMDA Health Care
- IHRT Consumer Discretionary
- Exchange
- KMDA Nasdaq
- IHRT Nasdaq
- Market Cap
- KMDA 349.6M
- IHRT 289.7M
- IPO Year
- KMDA N/A
- IHRT 2019
- Fundamental
- Price
- KMDA $7.16
- IHRT $2.33
- Analyst Decision
- KMDA Strong Buy
- IHRT Buy
- Analyst Count
- KMDA 2
- IHRT 3
- Target Price
- KMDA $14.50
- IHRT $3.00
- AVG Volume (30 Days)
- KMDA 142.0K
- IHRT 894.2K
- Earning Date
- KMDA 03-05-2025
- IHRT 02-27-2025
- Dividend Yield
- KMDA N/A
- IHRT N/A
- EPS Growth
- KMDA 124.29
- IHRT N/A
- EPS
- KMDA 0.27
- IHRT N/A
- Revenue
- KMDA $158,380,000.00
- IHRT $3,803,046,000.00
- Revenue This Year
- KMDA $15.81
- IHRT $6.16
- Revenue Next Year
- KMDA $5.79
- IHRT N/A
- P/E Ratio
- KMDA $26.36
- IHRT N/A
- Revenue Growth
- KMDA 4.52
- IHRT N/A
- 52 Week Low
- KMDA $4.74
- IHRT $0.81
- 52 Week High
- KMDA $8.00
- IHRT $3.04
- Technical
- Relative Strength Index (RSI)
- KMDA 70.04
- IHRT 60.58
- Support Level
- KMDA $7.00
- IHRT $1.81
- Resistance Level
- KMDA $8.00
- IHRT $2.22
- Average True Range (ATR)
- KMDA 0.31
- IHRT 0.15
- MACD
- KMDA 0.06
- IHRT 0.04
- Stochastic Oscillator
- KMDA 60.93
- IHRT 96.33
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About IHRT iHeartMedia Inc.
iHeartMedia Inc is a United States-based diversified media and entertainment company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.